EMA Discusses Disruptive Impact Of ‘Bad Submission Planning’ By Pharma

 
• By Vibha Sharma
  
Businessman with aspiration of becoming superhero
Companies Should Avoid Being Overly Optimistic When Deciding On Their Planned Filing Date (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pathways & Standards

More from Agency Leadership